Report - NDA 20987-S56 NDA 22020-S18 SUPPLEMENT APPROVAL...1 2 NDA 20987-S56 NDA 22020-S18 Page 2 Discontinue PROTONIX and evaluate patients with suspected acute TIN. [see Contraindications

Please pass captcha verification before submit form